Mitsubishi Tanabe Pharma Corporation Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2018; Provides Earnings Guidance for the First Half Ending September 2018 and Full Year Ending March 31, 2019
For the six months ending September 2018, the company expects revenue of ¥210,000 million, core ordinary profit of ¥30,000 million, operating profit of ¥28,500 million, profit before income tax was ¥29,000 million and profit attributable to owners of parent of ¥19,500 million or basic earnings per share of ¥34.77.
For the year ending March 31, 2019, the company expects revenue of ¥435,000 million, core ordinary profit of ¥70,000 million, operating profit of ¥67,000 million, profit before income tax was ¥67,500 million and profit attributable to owners of parent of ¥47,000 million or basic earnings per share of ¥83.81.